Treatment of Parkinsons Disease with Enhanced Delivery of Antibody Therapy Selectively Targeting Toxic Protein Variants Treatment of Parkinsons Disease with enhanced delivery of antibody therapy selectively targeting toxic protein variants
|Effective start/end date||3/1/17 → 11/30/21|
- Arizona Biomedical Research Commission: $750,000.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.